. Created with Sketch. , page-5. Australia's largest stock trading and investment forum Australia's #1 stock forumInvex Successfully Concludes Protocol Assistance with EMA, page-2. DJPIN. 2. Appreciate your input Dr T. a shell trading below cash backing, ripe. ASX - By Stock. here (arrow) per the NEU chart Close now to breaking trend and establishing a more upper trend into results IMO IXC Price at posting: 40. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. AX stock on Yahoo Finance. IXC on the other hand with nearer catalysts has already done its basing cycle Of course different stock different TAMS etc etc, probably why IMU is worth 640 mill MC and IXC 28 mill MC But again its why IXC is offering so much more in terms of value atm plus risk v reward All IMO of course, but yeh maybe some IMU investors pop across. Market . Date of AGM and Closing Date for Director NominationsCD is on the money once again, page-195. Last research or update on this I listened to was by FiftyOneCapital. Market . Invex Granted Type C Meeting with FDA, page-3. Invex Therapeutics Lists on ASXNo worries mate :), page-15. Invex to Present at Upcoming Tech Biotech Broker BriefingCreated with Sketch. Thought Id reshare as both now into phase 3 trials fully funded (please bare in mind 2. 10 Upvote. It was well aware of the claims made, released such information in the prospectus (and still had a hugely successful IPO), and would have done their due diligence before entering into any agreements with the University. Top Smart Score Stocks. Liked by Jackie Cox-Ziegler, CPHR. Just a matter of time really. IXC. 5 cents. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. 10 cents a week and we will be at $2 plus in no time. Created with Sketch. , page-5. ASX - Day Trading. . 3¢. . 1950. Charts. More. 0 Great. Contrast that to data from Wales in 2017 which suggests that. 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. Andrew Forrest , or his entities have been involved with IXC since inception. ASX - Day TradingI bought some today at 44. Results of MeetingFor those curious about the T20 moves over the last 2 months of available data;Underlined = UnchangedGreen = Positive ChangeRed = Negative ChangeDYOR, not. , page-196. Created with Sketch. Share A few weeks ago in the lead up to the Phase 2 results invex included this slide on their slide deck - 'average 42 million increase in market cap after positive Phase 2 results'. ASX - General. But posts 3-4 times a day that are the same charts we can all see, about a -3% move on $10k volume, paired with hysteria and paranoia, its just not. ASX - By Stock. . ASX - Day TradingAlthough with IXC fully cashed up it makes this fall irrational and the odd one out of alot of these small cap speccies that are death spiralling - aka, opportunity . EGREcoGraf partners with VinES Energy for pioneering Battery Anode Material Facility in Vietnam. Created with Sketch. ASX - By Stock. ASX - Day TradingInitial FDA and EMA Advice on Presendin Development, page-2. Market . IXC below Example of that is NEUInvestor Presentation, page-3. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. IXC – iShares Global Energy ETF – Check IXC price, review total assets, see historical growth, and review the. ASX - By Stock. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-7. Charts. 6B TAM that is unencumbered and a 55% peer average neurology success rate from Phase 3!IXC although only the 1 indication has already raised the sufficient cash to go all the way, they are in phase 3 trials, they have a time line and are full steam ahead. ASX - Day Trading. sentiment based on opinions from HotCopper and others. ASX - Day TradingCreated with Sketch. Created with Sketch. 76 (-1. ASX - Day TradingMEDSAFE and Ethics Approval for IIH EVOLVE Trial in NZCreated with Sketch. 0. TRP also trades sub cash -5m i believe, haven't checked in a while. Login to your CommSec account to buy. I'm topping up. ASX - By Stock. , page-5. Share Not unexpected. Market . . Latest Posts. ASX - By Stock. . Last updated 15. ASX - By Stock. Currency in USD 38. ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. In the LinkedIn About section for IXC, they list IIH, Acute Stroke and Traumatic Brain Injury. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Created with Sketch. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Advertise on HotCopper. . **Close price adjusted for splits and dividend and/or capital gain distributions. 15M !Invex to Present at Bell Potter Healthcare ConferenceNotice of Annual General Meeting/Proxy Form, page-3. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-3. Latest Posts. Transparency is our policy. . 0. . Forums. Anyone had a look at this or put an application in for some stock in the IPO?Created with Sketch. , page-3. 8,369 likes · 140 talking about this · 1,407 were here. , page-2. Charts. . 0. Last updated 10. My. 31% more bullish than other Healthcare sector stocks. 1. Been. ASX - Day TradingCreated with Sketch. . This was roughly 50/50 between lost wages and direct medical costs. no point selling now. 0. Created with Sketch. ASX - Day Trading. ASX - Short Term Trading. Discover historical prices for IXC. Advertise on HotCopper. Created with Sketch. Friday we moved 55% off 690k volume. ASX - By Stock. Learn more. Market Cap $16. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-6. It's essentially a cashed up shell company right now it. At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Consequently, this would result in faster market penetration and an accelerated timeline to peak sales. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. Created with Sketch. ASX - Short Term Trading. . Forums. A new thread to put trading comments / reasoning / opinions in. , page-6. British Columbia, Selkirk Mountains. ASX - General. Forums. Market . Market Wrap - Top 3 Gainers #ASXGainers: $IXC 54. 5% last year. 30 order I had out there for 2-3 weeks. Created with Sketch. 0 Great. Created with Sketch. . All IMO IXC Price at posting: 37. Forums. ASX. Created with Sketch. Should jump back in Titans, was good having you on board as you know your stuff IXC Price at posting: 57. ASX - By Stock. Forums. Created with Sketch. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentCreated with Sketch. 79 -0. Created with Sketch. Management have earmarked this a significant milestone - given they previously tied it to performance. 6% $DLM 50. Theres alot of breakdowns above that are yet to be backtested. Market . But lets not talk about NSB here, we are here to see progress with IXC. . , page-4. 00 over the course of 2 years, and then doubled to $14 overnight on FDA approval. Invex Granted Key European Patent for Exenatide, page-2. 06KBNotification of cessation of securities - IXC. Latest Posts Forums iShares Global Energy ETF (IXC) Add to watchlist NYSEArca - Nasdaq Real Time Price. With a team of 68. Charts. Created with Sketch. More progress made towards the start of Phase III, we have now made it on to the clinicltrials. Below is the broker data for IXC November to. , page-75. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportA new thread to put trading comments / reasoning / opinions in. ASX - Day TradingHere's a very good opportunity for people in Sydney. At that time the total costs of IIH exceeded $444,000,000. Latest Posts. 5¢ Sentiment: Buy Disclosure: Held Ive compared IXC to NEU before and believe we approx. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumFound this article a while back although raises some decent points. These are 2007 numbers. . Postcard to ShareholdersIXC (ASX) Ann: Trading Halt - HotCopper. Charts. ASX - Short Term Trading. Forums. 1. Invex Granted Type C Meeting with FDAAppendix 4E and Annual Report to shareholders. Forums. Latest Posts. Created with Sketch. Latest Posts ForumsHalf Yearly Report and AccountsWith debt too expensive and lots of very discounted capital raisings especially in the microcap part of the market, I'd like to think that IXC can take advantage of the fact that they have cash. Toubani Resources is an exploration and development company with a focus on developing a gold platform in West Africa. ASX - By Stock. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only a handful of posts discussing the fundamental analysis of the business itself,Publication of Invex IIH Phase II Pressure Trial Results. . 9MB OEC: 22/11/2023 1:05 PM : Cleansing Notice 2 pages 172. Ceasing to be a substantial holder. Management ticking boxes while shareholders continue to have a golden opportunity to invest near all time lows in a company that has continually de-risked the fundamentals thesis. 63%. ASX - By Stock. Latest Posts ForumsHalf Yearly Report and AccountsLooks like people are starting to wake up here and realise how bloody cheap IXC is. Share "Online registration will open 30 minutes before the Meeting. Charts. Market . Also took placement stock @$1. , page-5. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure. About 90 percent of the U. Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. . . ASX - Day Trading. ASX - Day TradingTo name a few other biotechs that have gotten belted by the market of the last few months that have had decent bounces such as NOX, NYR and PEB. . . @FullMoonFever Another chart request if you are up for it please thanks in advance, page-8. 1. ASX - Short Term Trading. ASX - By Stock. IXC Valuation Report MST. . Charts. . IXC (ASX) Ann: Trading Halt - HotCopper. I'm thinking of flying there myself!Prof Alex Sinclair is to present in Melbourne and Sydney next. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-3. Currency in USD 38. P3 will be kicked off in early CY2021. Created with Sketch. They have acted appropriately. Latest Posts. Created with Sketch. Below is the broker data for IXC November to. ASX - General. ASX - Day TradingIXC: 22/11/2023 1:08 PM : Notification of cessation of securities - IXC 4 pages 23. IXC Price at posting: 38. ASX - Day TradingCreated with Sketch. ASX - By Stock. ASX - General. Created with Sketch. IXC below Example of that is NEU Investor Presentation, page-3. Forums. Forums. Advertise on HotCopper. ASX - General. Market . , page-4. Also took placement stock @$1. Appendix 4E and Annual Report, page-2. Hopefully that placement overhang will be removed today tomorrow and the share price will catch up. Created with Sketch. *Close price adjusted for splits. Market . Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Share No great change in the top 2 big boys who hold 17% of the company, Twiggy's fund unchanged. AdINVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC. 69KBThis doesn't mean that IXC is doomed, just that things are more a gamble than an investment at the moment. ASX - Day TradingAnother day…another approval. ASX - By Stock. 026. INVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-9 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC. Latest Posts. IXC Price at posting. Australian finance news, stock quotes, currency information and blogs Active Funds. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. is 19. . Interexchange Carrier, also known as IXC, is a telco that mainly provides long-distance communication services. 0% $ODM 35. Very impressive. Created with Sketch. June 23 (Reuters) - Invex Therapeutics Ltd (IXC) : GRANTING OF ORPHAN DRUG DESIGNATION FOR EXENATIDE IN TREATMENT OF MODERATE TO SEVERE TRAUMATIC BRAIN. Charts. LoginJoin Now. Information. Created with Sketch. 7% #asx #ausbiz 23 Jun 2023 06:06:11. 31% more bullish than other Healthcare sector stocks. 2 years ago biotech stocks were in vogue and hence NEU was fairly priced at $1. 3¢. 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. . , page-136. Im not expecting anything out of the ordinary apart from the fact thats its overdone and too undervalued at the stage its at. Created with Sketch. Just unfortunate to hit the black swan so badly here, both the. Notice of Investor Call and Presentation, page-2. 333334. Created with Sketch. . The Phase III raise encompassed the costs for a go-it-alone reformulation strategy, with Bell Potter suggesting in a Q&A with IXC that they saved $5-6M in going with Peptron for their reformulation supply/manufacturing, alongside 12 months in time. Created with Sketch. Discover historical prices for IXC. 64440. Most bio's get acquired on P2 readouts, if results are strong early here. Interexchange Carrier, also known as IXC, is a telco that mainly provides long-distance communication services. AVALANCHE. Latest Posts. ASX - By Stock. Last updated 10. Last updated 10. 5¢ Sentiment: Hold Disclosure: Held IXC Valuation Report MST. Thought that this would be worthy of its own thread, a great starting place for those new to IXC and arguably the best presentation to date, Worth a. Forex. . Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumUK R&D Tax Rebate. ASX - Day Trading. . , page-2. ASX - By Stock. Latest Posts. ASX - By Stock. Very tempted to buy them back today at 19c. Market . Market . Last edited by jellyroll: 27/02/23. I'm talking about the period of the announcement about trials None of them moved apart from retailers that hosed out over 3 mill in shares. gov and there is lots of good information about the trial. Plans & Pricing. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Created with Sketch. I knew zero about the fundamentals of IXC. IXC Valuation Report MST. Share Appreciate the commentary and post. Join the HotCopper ASX share market forum today for free. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. 59). Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. ASX - By Stock. Release Date: 21/11/22 08:18; Summary: First Patient Randomised in IIH EVOLVE Phase III Trial; Price Sensitive: Yes; Download Document 205. . $100-200k might be the minimum for the market to take notice. Will management look for an early exit or are they wanting to take to market? Just came across IXC from another stock @JabraD posts on. US data averaged $2314 per person in direct medical care, the total average direct cost per IIH admission was 4x that or $9256. Created with Sketch. ASX - Short Term Trading. A neurosurgeon from Mercer Island and a noted mountaineer from Spokane, Washington, were killed on February 4, 1986, when. Interexchange carriers (IXCs) own or share the various high-bandwidth, fiber-optic trunk lines that cross the country and provide high-speed switched digital services for voice, data, and video communication. So your thesis is right on a long time time frame. 0¢ Sentiment: Buy Disclosure: Held. , page-2. Created with Sketch. Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-2. Invex Receives Approval for Paediatric Plan from the EMA, page-3. ASX - By Stock. Invex Therapeutics Lists on ASX, page-3. .